|
Wang, J K; Ju, S T; Marshak-Rothstein, A (2000) Protection of T cells from activation-induced cell death by Fas+ B cells. Eur J Immunol 30:931-7
|
|
Gochuico, B R; Zhang, J; Ma, B Y et al. (2000) TRAIL expression in vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 278:L1045-50
|
|
Xiao, S; Matsui, K; Fine, A et al. (1999) FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Eur J Immunol 29:3456-65
|
|
Van Parijs, L; Biuckians, A; Abbas, A K (1998) Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J Immunol 160:2065-71
|
|
Van Parijs, L; Peterson, D A; Abbas, A K (1998) The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8:265-74
|
|
Refaeli, Y; Van Parijs, L; London, C A et al. (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615-23
|
|
Rifkin, I R; Channavajhala, P L; Kiefer, H L et al. (1998) Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. J Immunol 161:5164-70
|
|
Matsui, K; Fine, A; Zhu, B et al. (1998) Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol 161:3469-73
|
|
Van Parijs, L; Biuckians, A; Ibragimov, A et al. (1997) Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol 158:3738-45
|
|
Wang, J K; Zhu, B; Ju, S T et al. (1997) CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL. Cell Immunol 179:153-64
|
Showing the most recent 10 out of 19 publications
